Nucleic-Acid Based Therapeutics (Technical Insights)
Nucleic-Acid Based Therapeutics (Technical Insights)
Strategic Portfolio Management
30-Dec-2011
Global
Technology Research
Description
The nucleic acid drugs sector consists of three major sub-sectors--aptamer therapeutics, antisense therapeutics, and RNA interference. Recent partnerships and alliances show an amalgamation of collaborations for discovery platforms and delivery technologies as well as drug entities. This report analyzes the R&D portfolio trends in these sub-sectors and then uses the Analytical Hierarchy Process (AHP) to prioritize different options that can be executed to design a strategic R&D portfolio,which showcases a company’s innovation capacity and also leads to higher credibility among investors. Portfolio options have been prioritized on a disease basis which is the one commonly followed by both big pharmaceuticals and biotech companies.
Table of Contents
Nucleic-Acid Based Therapeutics
- Nucleic-Acid Based Therapeutics
Growth dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
Popular Topics
Deliverable Type | Technology Research |
---|---|
No Index | Yes |
Podcast | No |
Author | Ipshita Chakraborty |
Industries | Healthcare |
WIP Number | D2C6-01-00-00-00 |
Is Prebook | No |